vimarsana.com

Latest Breaking News On - Laetitia rouxel - Page 1 : vimarsana.com

Evotec : Additional Information regarding agenda item 5 (Approval of Remuneration Report)

Additional Information regarding agenda item 5 As disclosed in the Remuneration Report 2023 a sign on bonus was granted by the Supervisory Board.

Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript

Evotec SE Preliminary Fiscal Year 2022 Results: Ahead of the Curve

Drug discovery company Evotec hopes for strong jump in profits

With weighty collaborations behind it, Hamburg-based pharmaceutical drug discovery company Evotec hopes for a better run in the future. In 2023, operating profit is expected to increase significantly,. | March 28, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.